Literature DB >> 10841131

Risk of cryptogenic fibrosing alveolitis in metal workers.

R Hubbard, M Cooper, M Antoniak, A Venn, S Khan, I Johnston, S Lewis, J Britton.   

Abstract

We report increased proportional mortality from cryptogenic fibrosing alveolitis in the workforce of a major UK engineering company. Measures of metal exposure from unbiased historical occupational records showed that among employees who have worked with metal, the risk of death from or with cryptogenic fibrosing alveolitis increased in relation to the duration of metal-working.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10841131     DOI： 10.1016/S0140-6736(00)82017-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  21 in total

1.  Occupational exposure in patients with the antisynthetase syndrome.

Authors:  Ane Labirua-Iturburu; Albert Selva-O'Callaghan; Jan-Paul Zock; Ramon Orriols; Xavier Martínez-Gómez; Miquel Vilardell-Tarrés
Journal:  Clin Rheumatol       Date:  2014-01-03       Impact factor: 2.980

Review 2.  Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways.

Authors:  Christopher M Evans; Tasha E Fingerlin; Marvin I Schwarz; David Lynch; Jonathan Kurche; Laura Warg; Ivana V Yang; David A Schwartz
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

3.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

4.  UK asbestos imports and mortality due to idiopathic pulmonary fibrosis.

Authors:  C M Barber; R E Wiggans; C Young; D Fishwick
Journal:  Occup Med (Lond)       Date:  2015-10-28       Impact factor: 1.611

5.  Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung Disease.

Authors:  Margaret L Salisbury; Justin C Hewlett; Guixiao Ding; Cheryl R Markin; Katrina Douglas; Wendi Mason; Adam Guttentag; John A Phillips; Joy D Cogan; Sara Reiss; Daphne B Mitchell; Pingsheng Wu; Lisa R Young; Lisa H Lancaster; James E Loyd; Stephen M Humphries; David A Lynch; Jonathan A Kropski; Timothy S Blackwell
Journal:  Am J Respir Crit Care Med       Date:  2020-05-15       Impact factor: 21.405

Review 6.  Asbestosis and environmental causes of usual interstitial pneumonia.

Authors:  Mridu Gulati; Carrie A Redlich
Journal:  Curr Opin Pulm Med       Date:  2015-03       Impact factor: 3.155

Review 7.  Newly recognized occupational and environmental causes of chronic terminal airways and parenchymal lung disease.

Authors:  Maor Sauler; Mridu Gulati
Journal:  Clin Chest Med       Date:  2012-12       Impact factor: 2.878

8.  Asbestosis and other pulmonary fibrosis in asbestos-exposed workers: high-resolution CT features with pathological correlations.

Authors:  Hiroaki Arakawa; Takumi Kishimoto; Kazuto Ashizawa; Katsuya Kato; Kenzo Okamoto; Koichi Honma; Seiji Hayashi; Masanori Akira
Journal:  Eur Radiol       Date:  2015-09-03       Impact factor: 5.315

Review 9.  The epidemiology of interstitial lung disease and its association with lung cancer.

Authors:  G Raghu; F Nyberg; G Morgan
Journal:  Br J Cancer       Date:  2004-08       Impact factor: 7.640

10.  Risk factors for the development of idiopathic pulmonary fibrosis: A review.

Authors:  Tanzira Zaman; Joyce S Lee
Journal:  Curr Pulmonol Rep       Date:  2018-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.